Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/10/23 → 4/10/25 |
Keywords
- Clinical trial
- 1042-TSC-3001
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (Trust TSC)
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Germaine, Jack (Project Manager)
Project: Research